AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2018
Nov 8, 2018
34931_dirs_2018-11-08_bef0e927-91bc-47ee-bdfc-f0da830a0194.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2018-11-07
Reporting Person: Schwalm Cynthia (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-07 | Restricted Stock Units | $0.0 | A | 12269 | Acquired | 2028-11-07 | Common Stock (12269.0) | Direct |
Footnotes
F1: Represents 12,269 shares of restricted stock units granted under the 2018 Equity Incentive Compensation Plan. The shares of restricted stock units will vest in annual installments over a three-year period with the initial vesting on November 7, 2019.